The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone

OBJECTIVE: To evaluate the long-term, real-life effects on non-motor symptoms (NMS) of opicapone compared to entacapone in levodopa-treated people with Parkinson’s disease (PwP). METHODS: A retrospective data analysis, with pre- and post-opicapone initiation data of 17 PwP with motor fluctuations co...

Descripción completa

Detalles Bibliográficos
Autores principales: Leta, Valentina, van Wamelen, Daniel J., Aureli, Federico, Metta, Vinod, Trivedi, Dhaval, Cortelli, Pietro, Rodriguez-Blazquez, Carmen, Rizos, Alexandra, Ray Chaudhuri, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293442/
https://www.ncbi.nlm.nih.gov/pubmed/37036498
http://dx.doi.org/10.1007/s00702-023-02603-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293442/
https://www.ncbi.nlm.nih.gov/pubmed/37036498
http://dx.doi.org/10.1007/s00702-023-02603-y

Ejemplares similares